May 1 |
AtriCure Reports First Quarter 2024 Financial Results
|
Apr 23 |
AtriCure upgraded at Oppenheimer on valuation
|
Apr 18 |
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
|
Apr 10 |
AtriCure to Announce First Quarter 2024 Financial Results
|
Mar 26 |
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 22 |
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
|
Mar 7 |
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
|
Feb 28 |
AtriCure (ATRC) Fell on Competitor Action
|
Feb 17 |
AtriCure Full Year 2023 Earnings: EPS Beats Expectations
|
Feb 16 |
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
|